Financial reports
10-Q
2024 Q2
Quarterly report
2 Aug 24
10-Q
2024 Q1
Quarterly report
1 May 24
ARS
2023 FY
Annual report to shareholders
8 Apr 24
10-K
2023 FY
Annual report
16 Feb 24
10-Q
2023 Q3
Quarterly report
1 Nov 23
10-Q
2023 Q2
Quarterly report
3 Aug 23
10-Q
2023 Q1
Quarterly report
3 May 23
ARS
2022 FY
Annual report to shareholders
4 Apr 23
10-K
2022 FY
Annual report
21 Feb 23
10-Q
2022 Q3
Quarterly report
3 Nov 22
Current reports
8-K
Other Events
20 Aug 24
8-K
Other Events
24 Jul 24
8-K
Other Events
22 Jul 24
8-K
Regulation FD Disclosure
12 Jul 24
8-K
Results of Operations and Financial Condition
12 Jul 24
8-K
Agenda Page 1 Overview 1 2 2024 Supervisory Severely Adverse Scenario results 3 3 Risks and methodologies 10
28 Jun 24
8-K
JPMorgan Chase Plans Dividend Increase and Has Authorized a New Common Share Repurchase Program
28 Jun 24
8-K
Other Events
3 Jun 24
8-K
Departure of Directors or Certain Officers
23 May 24
8-K
Regulation FD Disclosure
20 May 24
Registration and prospectus
424B2
Prospectus for primary offering
6 Sep 24
424B2
Prospectus for primary offering
6 Sep 24
424B2
Prospectus for primary offering
6 Sep 24
424B2
Prospectus for primary offering
6 Sep 24
424B2
Prospectus for primary offering
6 Sep 24
424B2
Prospectus for primary offering
6 Sep 24
424B2
Prospectus for primary offering
6 Sep 24
424B2
Prospectus for primary offering
6 Sep 24
424B2
Prospectus for primary offering
6 Sep 24
424B2
Prospectus for primary offering
6 Sep 24
Proxies
DEFA14A
Additional proxy soliciting materials
13 May 24
DEFA14A
Additional proxy soliciting materials
8 May 24
PX14A6G
Letter to shareholders
30 Apr 24
DEFA14A
Additional proxy soliciting materials
25 Apr 24
PX14A6G
Letter to shareholders
24 Apr 24
PX14A6G
Letter to shareholders
23 Apr 24
PX14A6G
Letter to shareholders
22 Apr 24
PX14A6G
Letter to shareholders
12 Apr 24
DEFA14A
Additional proxy soliciting materials
8 Apr 24
DEF 14A
Definitive proxy
8 Apr 24
Other
IRAN
Disclosure regarding Iran Threat Reduction and Syria Human Rights Act
16 Feb 24
EFFECT
Notice of effectiveness
7 Feb 24
CERT
Certification of approval for exchange listing
26 Jan 24
IRAN
Disclosure regarding Iran Threat Reduction and Syria Human Rights Act
1 Nov 23
IRAN
Disclosure regarding Iran Threat Reduction and Syria Human Rights Act
3 Aug 23
EFFECT
Notice of effectiveness
14 Apr 23
CORRESP
Correspondence with SEC
10 Apr 23
UPLOAD
Letter from SEC
3 Mar 23
EFFECT
Notice of effectiveness
12 Apr 22
CORRESP
Correspondence with SEC
7 Apr 22
Ownership
SC 13G/A
Perimeter Solutions, SA
5 Sep 24
SC 13G/A
Outset Medical, Inc.
5 Sep 24
SC 13G/A
PUBLIC SERVICE ENTERPRISE GROUP INC
5 Sep 24
SC 13G/A
NLIGHT, INC.
5 Sep 24
13F-HR
Quarterly holdings report by institutional manager
12 Aug 24
SC 13G/A
MSA Safety Inc
9 Aug 24
SC 13G/A
CEDAR FAIR L P
9 Aug 24
SC 13G/A
ENERGIZER HOLDINGS, INC.
9 Aug 24
SC 13G/A
Twist Bioscience Corp
9 Aug 24
SC 13G/A
RADIAN GROUP INC
9 Aug 24